SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-15-008895
Filing Date
2015-02-13
Accepted
2015-02-13 14:07:55
Documents
1
Group Members
JAFCO CO., LTD.

Document Format Files

Seq Description Document Type Size
1 FORM SC 13G v401618_sc13g.htm SC 13G 53798
  Complete submission text file 0001144204-15-008895.txt   55455
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Subject) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87951 | Film No.: 15612583
SIC: 2834 Pharmaceutical Preparations

Mailing Address OTEMACHI FIRST SQUARE, WEST TOWER 11F 1-5-1 OTEMACHI CHIYODA-KU, TOKYO 100-0004 M0 100-0004
Business Address OTEMACHI FIRST SQUARE, WEST TOWER 11F 1-5-1 OTEMACHI CHIYODA-KU, TOKYO 100-0004 M0 100-0004 81-3-5223-7008
JAFCO Super V3 Investment Limited Partnership (Filed by) CIK: 0001590442 (see all company filings)

IRS No.: 980581564 | State of Incorp.: M0 | Fiscal Year End: 1231
Type: SC 13G